Tarsus Pharmaceuticals Inc (TARS) Transcripts
Q3 2024 Tarsus Pharmaceuticals Inc Earnings Call Transcript
Nov 13, 2024
$46.51
(-2.24%)
Earnings
Q2 2024 Tarsus Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2024
$23.61
(+4.05%)
Earnings
Q1 2024 Tarsus Pharmaceuticals Inc Earnings Call Transcript
May 08, 2024
$37.35
(-1.79%)
Earnings
Q4 2023 Tarsus Pharmaceuticals Inc Earnings Call Transcript
Feb 27, 2024
$39.22
(+18.28%)
Earnings
Q3 2023 Tarsus Pharmaceuticals Inc Earnings Call Transcript
Nov 09, 2023
$15.57
(-5.86%)
Earnings
Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript
Jul 25, 2023
Tarsus Pharmaceuticals Inc To Discuss Creating the Next Blockbuster Category in Eye Care Call Transcript
Jun 15, 2023
Tarsus Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Tarsus Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2023
Tarsus Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 13, 2023
Tarsus Pharmaceuticals Inc To Discuss Revolutionizing Treatment For Demodex Blepharitis Patients Call Transcript
Feb 08, 2022
Tarsus Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 08, 2021
Tarsus Pharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Jul 14, 2021
Tarsus Pharmaceuticals Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Tarsus Pharmaceuticals Inc Saturn-1 Pivotal Trial Topline Results Call Transcript
Jun 21, 2021